Nigericin selectively targets cancer stem cells in nasopharyngeal carcinoma

International Journal of Biochemistry and Cell Biology

Volumn 45, Issue 9, 2013, Pages 1997-2006

  Deng, Cheng Cheng ^a   Liang, Yi ^a   Wu, Man Si ^a   Feng, Fu Tuo ^a   Hu, Wen Rong ^a   Chen, Li Zhen ^a   Feng, Qi Sheng ^a   Bei, Jin Xin ^a   Zeng, Yi Xin ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Bmi 1; Cancer stem cells; Chemotherapy; Nasopharyngeal carcinoma; Nigericin

Indexed keywords

BMI1 PROTEIN; CISPLATIN; NIGERICIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER STEM CELL; CELL ASSAY; CELL INVASION; CELL MIGRATION; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; NASOPHARYNX CARCINOMA; STABLE TRANSFECTION; WESTERN BLOTTING;

BMI-1; CANCER STEM CELLS; CHEMOTHERAPY; NASOPHARYNGEAL CARCINOMA; NIGERICIN;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL LINE, TUMOR; CELL MOVEMENT; CISPLATIN; DOWN-REGULATION; DRUG SYNERGISM; HUMANS; IMMUNOHISTOCHEMISTRY; MICE; MICE, NUDE; NASOPHARYNGEAL NEOPLASMS; NEOPLASM METASTASIS; NEOPLASTIC STEM CELLS; NIGERICIN; POLYCOMB REPRESSIVE COMPLEX 1; RANDOM ALLOCATION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84885111650     PISSN: 13572725     EISSN: 18785875     Source Type: Journal    
DOI: 10.1016/j.biocel.2013.06.023     Document Type: Article

References (41)

1. Bao S, Wu Q, McLendon R.E., Hao Y., Shi Q, Hjelmeland AB, et al Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 2006; 444:756-60. (Pubitemid 44949604)
2. Chaffer CL, Brueckmann I, Scheel C, Kaestli AJ, Wiggins PA, Rodrigues LO, et al. Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state. Proceedings of the National Academy of Sciences of the United States of America 2011; 108:7950-5.
3. Cao L, Bombard J, Cintron K., Sheedy J, Weetall ML, et al BMI1 as a novel target for drug discovery in cancer. Journal of Cellular Biochemistry 2011; 112: 2729-41.
4. Chan AT. Nasopharyngeal carcinoma. Annals of Oncology: Official Journal of the European Society for Medical Oncology 2010; 21:308-12.
5. Charafe-Jauffret E., Ginestier C, Iovino F, Wicinski J, Cervera N, Finetti P, et al. Breast cancer cell lines contain functional cancer stem cells with metastatic capacity and a distinct molecular signature. Cancer Research 2009; 69:1302-13.
6. Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Advances in Enzyme Regulation 1984; 22:27-55.
7. Clarke MF, Dick JE, Dirks P.B., Eaves CJ, Jamieson CH, Jones DL, et al Cancer stem cells-perspectives on current status and future directions: AACR Workshop on cancer stem cells. Cancer Research 2006; 66:9339-44. (Pubitemid 44623625)
8. Fulda S, Pervaiz S. Apoptosis signaling in cancerstem cells. The International Journal of Biochemistry & Cell Biology 2010; 42:31-8.
9. Guigay J. Advances in nasopharyngeal carcinoma. Current Opinion in Oncology 2008; 20:264-9. (Pubitemid 351507545)
10. Gupta PB, Fillmore CM, Jiang G, Shapira S.D., Tao K., Kuperwasser C, et al Stochastic state transitions give rise to phenotypic equilibrium in populations of cancer cells. Cell 2011; 146:633-44.
11. Gupta PB, Onder TT, Jiang G, Tao K, Kuperwasser C, Weinberg RA, et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009; 138:645-59.
12. Hermann PC, Huber SL, Herrler T, Aicher A, Ellwart JW, Guba M, et al. Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer. Cell Stem Cell 2007; 1:313-23. (Pubitemid 47355323)
13. Hill R, Wu H. PTEN, stem cells, and cancer stem cells. The Journal of Biological Chemistry 2009; 284:11755-9.
14. Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, et al. Epstein-Barr Virus-Encoded LMP2A Induces an epithelial-mesenchymal transition and increases the number of side population stem-like cancer cells in nasopharyngeal carcinoma. PLoS Pathogens 2010; 6:1-14.
15. Li C, Heidt DG, Dalerba P, Burant CF, Zhang L, Adsay V, et al. Identification of pancreatic cancer stem cells. Cancer Research 2007a; 67:1030-7.
16. Li F, Tiede B, Massague J, Kang Y. Beyond tumorigenesis: cancer stem cells in metastasis. Cell Research 2007b; 17:3-14. (Pubitemid 46096419)
17. Li XJ, Ong CK, Cao Y, Xiang Y.Q., Shao JY, Ooi A, et al Serglycin is a theranostic target in nasopharyngeal carcinoma that promotes metastasis. Cancer Research 2011; 71:3162-72.
18. Liang Y, Zhong Z, Huang Y., Deng W, Cao J, Tsao G., et al Stem-like cancer cells are inducible by increasing genomic instability in cancer cells. The Journal of Biological Chemistry 2010; 285:4931-40.
19. Lo KW, To KF, Huang DP Focus on nasopharyngeal carcinoma. Cancer Cell 2004; 5:423-8. (Pubitemid 38612865)
20. Lu D, Choi MY, Yu J, Castro J.E., Kipps TJ, Carson DA Salinomycin inhibits Wnt signaling and selectively induces apoptosis in chronic lymphocytic leukemia cells. Proceedings of the National Academy of Sciences of the United States of America 2011; 108:13253-7.
21. Magee JA, Piskounova E, Morrison SJ. Cancer stem cells: impact, heterogeneity, and uncertainty. Cancer Cell 2012; 21:283-96.
22. Mani SA, Guo W, Liao M.J., Eaton EN, Ayyanan A, Zhou AY, et al The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133:704-15. (Pubitemid 351636299)
23. Nguyen LV, Vanner R, Dirks P., Eaves CJ Cancer stem cells an evolving concept. Nature Reviews 2012; 12:133-43.
24. O'Brien C.A., Pollett A, Gallinger S., Dick JE A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 2007; 445:106-10. (Pubitemid 46067310)
25. Pang R, Law WL, Chu A.C., Poon JT, Lam CS, Chow AK, et al A subpopulation of CD26+ cancer stem cells with metastatic capacity in human colorectal cancer. Cell Stem Cell 2010; 6:603-15.
26. Park IK, Morrison SJ, Clarke MF Bmi1, stem cells, and senescence regulation. Journal of Clinical Investigation 2004; 113:175-9. (Pubitemid 38544200)
27. Qian CN, Berghuis B, Tsarfaty G, Bruch M, Kort EJ, Ditlev J, et al. Preparing the soil: the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Research 2006; 66:10365-76. (Pubitemid 44799756)
28. Razak AR, Siu LL, Liu F.F., Ito E., O'Sullivan B, Chan K. Nasopharyngeal carcinoma: the next challenges. European Journal of Cancer 2010; 46:1967-78.
29. Reya T, Morrison SJ, Clarke M.F., Weissman IL Stem cells, cancer, and cancer stem cells. Nature 2001; 414:105-11. (Pubitemid 33041634)
30. Shavit N, Dilley RA, Pietro AS Ion Translocation in isolated chloroplasts. Uncoupling of photophosphorylation and translocation of K+ and H+ ions induced by nigericin. Biochemistry 1968; 7:2356-63.
31. Sheila K, Singh IDC, Mizuhiko T, Bonn VE, Cynthia H, Jeremy S, et al. Identification of a cancer stem cell in human brain tumors. Cancer Research 2003; 63:5812-28.
32. Siddique HR, Saleem M. Concise review: role of BMI1, a stem cell factor, in cancer recurrence and chemoresistance: preclinical and clinical evidences. Stem Cells 2012; 30:372-8.
33. Song LB, Zeng MS, Liao W.T., Zhang L., Mo HY, Liu WL, et al Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression and immortalizes primary human nasopharyngeal epithelial cells. Cancer Research 2006; 66:6225-32.
34. Song LB, Li J, Liao W.T., Feng Y., Yu CP, Hu LJ, et al The polycomb group protein Bmi-1 represses the tumor suppressor PTEN and induces epithelial-mesenchymal transition in human nasopharyngeal epithelial cells. Journal of Clinical Investigation 2009; 119:3626-36.
35. Tang QL, Zhao ZQ, Li J.C., Liang Y., Yin JQ, et al Salinomycin inhibits osteosarcoma by targeting its tumor stem cells. Cancer Letter 2011; 311:113-21.
36. Wang J, Guo LP, Chen L.Z., Zeng YX, Lu SH Identification of cancer stem cell-like side population cells in human nasopharyngeal carcinoma cell line. Cancer Research 2007; 67:3716-24. (Pubitemid 46762157)
37. Wei WI, Sham JST. Nasopharyngeal carcinoma. Lancet 2005; 365:2041-54. (Pubitemid 40812341)
38. Yu Z, Pestell TG, Lisanti M.P., Pestell RG Cancer stem cells. The International Journal of Biochemistry & Cell Biology 2012; 44:2144-51.
39. Zhang GN, Liang Y, Zhou L.J., Chen SP, Chen G, et al Combination of salinomycin and gemcitabine eliminates pancreatic cancer cells. Cancer Letter 2011; 313:137-44.
40. Zhang S, Balch C, Chan M.W., Lai HC, Matei D, Schilder JM, et al Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Research 2008; 68:4311-20.
41. Zhou HM, Dong TT, Wang L.L., Feng B., Zhao HC, Fan XK, et al. Suppression of colorectal cancer metastasis by nigericin through inhibition of epithelial-mesenchymal transition. World Journal of Gastroenterology 2012; 18:2640-8.